First melanoma drug in 13 years: SAA lab at Sloan Kettering

Our lab gets it done in the fight against melanoma.

For those of you who may have missed the NBC Nightly News last night, there was excellent coverage of Jedd Wolchok, who heads up our Swim Across America Laboratory at Memorial Sloan Kettering.  As most of you know, last year, the SAA Lab was responsible for developing ipilumumab, the first melanoma drug, to be approved by the FDA in over 13 years.

Jedd and his team are now taking that drug and in combination with radiation seeing even more promising results and hopes that the same approach they are doing for melanoma could work with kidney, lung and other cancers.
Jedd, we are so proud to continue to support all the incredible research that you and your team are doing at MSK. Please pass along our congratulations to your team and keep us in the loop on your further discoveries!  You are doing incredible work!
Everyone, please take time to watch and read the attached link below…..and feel free to forward it along to your local committees.
Best, Janel
Swim Across America Executive Director
Categories: Uncategorized | Leave a comment

Post navigation

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Blog at

%d bloggers like this: